Kiyosue A, et al. - The safety and efficacy of liraglutide in combination with one oral antidiabetic drug (OAD) across different OAD classes were examined. The clinicians proposed that without impacting tolerability, Japanese patients on OAD monotherapy could benefit from a greater improvement in glycemic control, by combining their OAD with liraglutide rather than another OAD, regardless of which OAD monotherapy they are receiving.